Relugolix Impurity 85 | CAS 5332-96-7 - Request Quote
Relugolix Impurity 85
| SZ CAT No: | SZ-R051096 |
| CAS No | 5332-96-7 |
| Mol.F. | C9H9NO3 |
| Mol.Wt. | 179.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Relugolix Impurity 85 is chemically 1-(4-Nitrophenyl)propan-2-one. Relugolix Impurity 85 is supplied with detailed characterization data compliant with regulatory guideline. Relugolix Impurity 85 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Relugolix.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 5332-96-7
Purchase 5332-96-7
Order 5332-96-7
Enquire 5332-96-7
price of 5332-96-7
5332-96-7 Supplier
5332-96-7 Manufacturer
5332-96-7 Exporter
buy high quality Relugolix Impurity 85
Purchase Relugolix Impurity 85
Relugolix Impurity 85 suppliers
Relugolix Impurity 85 manufacturers
Relugolix Impurity 85 price
Order Relugolix Impurity 85
Enquire Relugolix Impurity 85
Relugolix Impurity 85 cost
Relugolix Impurity 85 Supplier
Relugolix Impurity 85 Distributor
Relugolix Impurity 85 for Method Validation
Relugolix Reference Standard
Relugolix Impurity 85 for ANDA Filing
Relugolix Impurity 85 for Forced Degradation Studies
Relugolix Impurity 85 Identification Standards
Relugolix Impurity 85 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


